Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

58.94
+1.162.00%
Volume:149.40K
Turnover:8.71M
Market Cap:8.25B
PE:39.95
High:59.05
Open:57.79
Low:57.06
Close:57.78
52wk High:76.76
52wk Low:9.57
Shares:140.01M
Float Shares:120.00M
Volume Ratio:0.41
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.48
EPS(LYR):-0.0122
ROE:75.50%
ROA:14.35%
PB:14.52
PE(LYR):-4,833.51

Loading ...

Jan 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]